Carisma Therapeutics Joins 7th Annual Evercore ISI HealthCONx Conference To Share Industry Insights
Carisma CEO Steven Kelly to join a fireside chat at the Evercore ISI HealthCONx Conference on Dec 5. Webcast available on company site.
Carisma Therapeutics Inc. (Nasdaq: CARM), a clinical-stage biopharmaceutical company dedicated to pioneering innovative immunotherapies, has announced that Steven Kelly, President and CEO, will take part in a fireside chat at the 7th Annual Evercore ISI HealthCONx Conference. The session is scheduled for Thursday, December 5th at 9:35 am ET. An audio webcast of the discussion will be accessible on the Company's Investor Events page within the Investor Relations section of its website and will be available for a limited period after the event.
Simantini Singh Deo works on the latest and trending news happening daily in the pharma world.
More from Pharma News
All stories →
Bristol-Myers Squibb Gains FDA Accelerated Approval for Iberdomide in Relapsed or Refractory Multiple Myeloma
Eton Pharmaceuticals Gains FDA Fast Track for AMGLIDIA and Targets 2027 NDA with ASN-001 Acquisition
Discussion